Integrin Targeted Therapeutics
<p>Integrins are heterodimeric, transmembrane receptors that function as mechanosensors, adhesion molecules and signal transduction platforms in a multitude of biological processes. As such, integrins are central to the etiology and pathology of many disease states. Therefore, pharmacological...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2011-01-01
|
Series: | Theranostics |
Online Access: | http://www.thno.org/v01p0154.htm |
id |
doaj-d088c92cbd2245ceb31135277e75b471 |
---|---|
record_format |
Article |
spelling |
doaj-d088c92cbd2245ceb31135277e75b4712020-11-25T00:25:23ZengIvyspring International PublisherTheranostics1838-76402011-01-0111154188Integrin Targeted TherapeuticsMelissa Millard, Srinivas Odde, Nouri Neamati<p>Integrins are heterodimeric, transmembrane receptors that function as mechanosensors, adhesion molecules and signal transduction platforms in a multitude of biological processes. As such, integrins are central to the etiology and pathology of many disease states. Therefore, pharmacological inhibition of integrins is of great interest for the treatment and prevention of disease. In the last two decades several integrin-targeted drugs have made their way into clinical use, many others are in clinical trials and still more are showing promise as they advance through preclinical development. Herein, this review examines and evaluates the various drugs and compounds targeting integrins and the disease states in which they are implicated.</p>http://www.thno.org/v01p0154.htm |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Melissa Millard, Srinivas Odde, Nouri Neamati |
spellingShingle |
Melissa Millard, Srinivas Odde, Nouri Neamati Integrin Targeted Therapeutics Theranostics |
author_facet |
Melissa Millard, Srinivas Odde, Nouri Neamati |
author_sort |
Melissa Millard, Srinivas Odde, Nouri Neamati |
title |
Integrin Targeted Therapeutics |
title_short |
Integrin Targeted Therapeutics |
title_full |
Integrin Targeted Therapeutics |
title_fullStr |
Integrin Targeted Therapeutics |
title_full_unstemmed |
Integrin Targeted Therapeutics |
title_sort |
integrin targeted therapeutics |
publisher |
Ivyspring International Publisher |
series |
Theranostics |
issn |
1838-7640 |
publishDate |
2011-01-01 |
description |
<p>Integrins are heterodimeric, transmembrane receptors that function as mechanosensors, adhesion molecules and signal transduction platforms in a multitude of biological processes. As such, integrins are central to the etiology and pathology of many disease states. Therefore, pharmacological inhibition of integrins is of great interest for the treatment and prevention of disease. In the last two decades several integrin-targeted drugs have made their way into clinical use, many others are in clinical trials and still more are showing promise as they advance through preclinical development. Herein, this review examines and evaluates the various drugs and compounds targeting integrins and the disease states in which they are implicated.</p> |
url |
http://www.thno.org/v01p0154.htm |
work_keys_str_mv |
AT melissamillardsrinivasoddenourineamati integrintargetedtherapeutics |
_version_ |
1725349287776223232 |